BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 2788188)

  • 1. Membrane IgD and membrane IgM differ in capacity to transduce inhibitory signals within the same human B cell clonal populations.
    Mongini PK; Blessinger C; Posnett DN; Rudich SM
    J Immunol; 1989 Sep; 143(5):1565-74. PubMed ID: 2788188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B cell activation. V. Differentiation signaling of B cell membrane depolarization, increased I-A expression, G0 to G1 transition, and thymidine uptake by anti-IgM and anti-IgD antibodies.
    Cambier JC; Monroe JG
    J Immunol; 1984 Aug; 133(2):576-81. PubMed ID: 6610706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The riddle of the dual expression of IgM and IgD.
    Geisberger R; Lamers M; Achatz G
    Immunology; 2006 Aug; 118(4):429-37. PubMed ID: 16895553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane IgM influences membrane IgD mediated antigen internalization in the B cell line Bcl1.
    Geisberger R; Königsberger S; Achatz G
    Immunol Lett; 2006 Feb; 102(2):169-76. PubMed ID: 16219364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory and stimulatory signaling via immunoglobulin receptors: dichotomous responses elicited in clonal B cell populations.
    Van Endert PM; Moldenhauer G
    Eur J Immunol; 1992 May; 22(5):1229-35. PubMed ID: 1577065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cell tolerance induction by cross-linking of membrane IgM, but not IgD, and synergy by cross-linking of both isotypes.
    Gaur A; Yao XR; Scott DW
    J Immunol; 1993 Mar; 150(5):1663-9. PubMed ID: 8436810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo B lymphocyte-activating properties of monoclonal anti-delta antibodies. I. Determinants of B lymphocyte-activating properties.
    Goroff DK; Stall A; Mond JJ; Finkelman FD
    J Immunol; 1986 Apr; 136(7):2382-92. PubMed ID: 2419432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mIgM:mIgD ratios on B cells: mean mIgD expression exceeds mIgM by 10-fold on most splenic B cells.
    Havran WL; DiGiusto DL; Cambier JC
    J Immunol; 1984 Apr; 132(4):1712-6. PubMed ID: 6421926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane IgM and IgD molecules fail to transduce Ca2+ mobilizing signals when expressed on differentiated B lineage cells.
    Justement LB; Wienands J; Hombach J; Reth M; Cambier JC
    J Immunol; 1990 May; 144(9):3272-80. PubMed ID: 2109774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen receptor-triggered apoptosis in immature B cell lines is associated with the binding of a 44-kDa phosphoprotein to the PTP1C tyrosine phosphatase.
    Wu Y; Pani G; Siminovitch K; Hozumi N
    Eur J Immunol; 1995 Aug; 25(8):2279-84. PubMed ID: 7664792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane Ig-cytoskeletal interactions. I. Flow cytofluorometric and biochemical analysis of membrane IgM-cytoskeletal interactions.
    Albrecht DL; Noelle RJ
    J Immunol; 1988 Dec; 141(11):3915-22. PubMed ID: 3141508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyclonal activation of the murine immune system by an antibody to IgD. XI. Contribution of membrane IgD cross-linking to the generation of an in vivo polyclonal antibody response.
    Goroff DK; Holmes JM; Bazin H; Nisol F; Finkelman FD
    J Immunol; 1991 Jan; 146(1):18-25. PubMed ID: 1984444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human B cell activation. Effect of T cell cytokines on the physicochemical binding requirements for achieving cell cycle progression via the membrane IgM signaling pathway.
    Mongini PK; Highet PF; Inman JK
    J Immunol; 1995 Oct; 155(7):3385-400. PubMed ID: 7561033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane IgM-mediated signaling of human B cells. Effect of increased ligand binding site valency on the affinity and concentration requirements for inducing diverse stages of activation.
    Mongini PK; Blessinger CA; Highet PF; Inman JK
    J Immunol; 1992 Jun; 148(12):3892-901. PubMed ID: 1376344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies. Effects of B cell proliferation versus growth inhibition (tolerance) of an immature B cell lymphoma.
    Udhayakumar V; Kumar L; Subbarao B
    J Immunol; 1991 Jun; 146(12):4120-9. PubMed ID: 2040794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ligand-induced membrane IgM association with the cytoskeletal matrix of B cells is not mediated through the Ig alpha beta heterodimer.
    Hartwig JH; Jugloff LS; De Groot NJ; Grupp SA; Jongstra-Bilen J
    J Immunol; 1995 Oct; 155(8):3769-79. PubMed ID: 7561081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between lymphocyte membrane molecules. II. Characterization of an interaction between B lymphocyte surface IgD and Fc IgG receptors that differs from the surface IgM-Fc IgG receptor interaction.
    Dickler HB; Kubicek MT; Finkelman FD
    J Immunol; 1982 Mar; 128(3):1271-7. PubMed ID: 6799572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human pre-B and B cell membrane mu-chains are noncovalently associated with a disulfide-linked complex containing a product of the B29 gene.
    Clark MR; Friedrich RJ; Campbell KS; Cambier JC
    J Immunol; 1992 Nov; 149(9):2857-63. PubMed ID: 1401917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manipulating mIgD-expressing B cells with anti-migis-δ monoclonal antibodies.
    Chen NY; Hung AF; Lin CJ; Chen JB; Chu HM; Yu HM; Chang HY; Chang TW
    Mol Immunol; 2013 Mar; 53(3):187-97. PubMed ID: 22944457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
    Maruyama S; Kubagawa H; Cooper MD
    J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.